Cargando…
The N-terminal peptide of the main protease of SARS-CoV-2, targeting dimer interface, inhibits its proteolytic activity
The main protease (Mpro) of SARS-CoV-2 cleaves 11 sites of viral polypeptide chains and generates essential non-structural proteins for viral replication. Mpro is an important drug target against COVID-19. In this study, we developed a real-time fluorometric turn-on assay system to evaluate Mpro pro...
Autores principales: | Song, Sunyu, Kim, Yeseul, Kwak, Kiwoong, Lee, Hyeonmin, Park, Hyunjae, Kim, Young Bong, Lee, Hee-Jung, Kang, Lin-Woo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689081/ https://www.ncbi.nlm.nih.gov/pubmed/37817441 http://dx.doi.org/10.5483/BMBRep.2023-0153 |
Ejemplares similares
-
Structural Insights for β-Lactam Antibiotics
por: Kim, Dogyeoung, et al.
Publicado: (2023) -
Key dimer interface residues impact the catalytic activity of 3CLpro, the main protease of SARS-CoV-2
por: Ferreira, Juliana C., et al.
Publicado: (2022) -
C-terminal domain of SARS-CoV main protease can form a 3D domain-swapped dimer
por: Zhong, Nan, et al.
Publicado: (2009) -
Proteolytic Cleavage of Bioactive Peptides and Protease-Activated Receptors in Acute and Post-Colitis
por: De bruyn, Michelle, et al.
Publicado: (2021) -
Liberation of SARS-CoV main protease from the viral polyprotein: N-terminal autocleavage does not depend on the mature dimerization mode
por: Chen, Shuai, et al.
Publicado: (2010)